【Peir Biomedical-Innovation】Announcement of the Record Date for the Conversion of Employee Stock Warrants into Common Shares as Resolved by the Board of Directors

1. Date of board resolution: 115/05/05 (May 5, 2026) 2. Source of capital increase: Exercise of employee stock warrants converted into common shares 3. Is this a consolidated report for new share issuance (if yes, please specify the planned issuance period/no): No 4. Total amount and number of shares issued in this case (if it is a capital increase from earnings or capital reserves, the number of shares issued does not include those allocated to employees): Not applicable 5. For consolidated report cases, the amount and number of shares issued this time: Not applicable 6. For consolidated report cases, after this issuance, the remaining amount and number of shares: Not applicable 7. Par value per share: NT$10 8. Issuance price: Subscription price per share NT$20 9. Number of shares subscribed by employees or amount allocated: 667,500 shares 10. Number of shares for public sale: Not applicable 11. Proportion for original shareholders' subscription or free allocation: Not applicable 12. Handling of odd lots and unsubscribed shares after the deadline: Not applicable 13. Rights and obligations of these newly issued shares: Same as existing common shares 14. Purpose of this capital increase: To attract and retain talent needed by the company 15. Other matters to be specified: The record date for the capital increase is 115/05/05 (May 5, 2026)